Price to Sales ratio Analysis of Tango Therapeutics Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
17.45
Period Ending - Dec-22
Very Poor PS
24.45
Growth
-28.62 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
18.39
PS Analysis of Tango Therapeutics Inc
P/S Ratio of Tango Therapeutics Inc with value of 18.39 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of TNGX drastically fell by -28.62 % this year. |
PS Ratio with value of 79.07 was highest in Year Dec-20 in last Five Years. |
PS Ratio with value of 2.52 was lowest in Year Dec-19 in last Five Years. |
Latest PS Ratio with value of 17.45 is lower than Average PS of 25.32 in last five years. |
Other PS Related Info of TNGX that may interest you.
Tango Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
TNGX | 6.92 | 6.66 | 3.90 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of Tango Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
PS | 17.45 | 24.45 | 3.12 | 79.07 | 2.52 |
Change | -28.62 % | 684.73 % | -96.06 % | 3034.19 % |
FY Chart of Price to Sales of Tango Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)